LENZ Therapeutics and JIXING Announce an Exclusive Greater China[...]
LENZ Therapeutics Announces Positive Topline Data from Phase 2 INSIGHT[...]
LENZ Therapeutics Announces $83.5 Million Series B Financing to Advance[...]
06/13/2024 | Press release | Distributed by Public on 06/13/2024 03:08
Please select the service you want to use:
Smartlinks | AGSM AIM S.p.A. | News | Health | Company News | Securities Issuers | Private Companies | Multiline Utilities Companies | Corporate Debt Issuers
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact